Patrick J. Haley sold $1.9M of Exelixis (EXEL)

Executed Feb 24 2025, disclosed Feb 26 2025, 2 days later.

Value, as filed

$1.9M

52,636 sh × $36.98

Executed

Feb 24 2025

the trade date, as filed

Disclosed

Feb 26 2025

2 days after the trade

Return, 21 sessionsiFrom the disclosed entry session; derived

–

purchases only

Returns are measured on stock purchases only.

The filer

PH Patrick J. Haley EVP, Commercial profile →

Patrick J. Haley (EVP, Commercial) filed 3 Form 4 reports in the trailing twelve months (0 purchases, 3 sales), most often in Exelixis, Inc. (EXEL). The largest single filing was $3.0M of EXEL (72,230 sh across 4 lots, as filed), executed Nov 20 2025.

The name

EXEL Exelixis, Inc. EXEL · Healthcare · 53 filings in 24 months ticker →

Healthcare · Exelixis, Inc., an oncology company, focuses on the discovery, development, and commercialization of new medicines for difficult-to-treat c…

More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→

Other filings by Patrick J. Haley in EXEL

EXELSALE Exelixis, Inc. $1.6M
32,110 sh × $49.81
Exec May 20
Filed May 22 · 5:30 PM ET EXELSALE Exelixis, Inc. $3.0M
67,814 sh across 2 lots
Exec Feb 17
Filed Feb 18 · 5:30 PM ET EXELSALE Exelixis, Inc. $3.0M
72,230 sh across 4 lots
Exec Nov 20 2025
Filed Nov 24 2025 · 5:30 PM ET EXELSALE Exelixis, Inc. $1.5M
34,387 sh × $44.06
Exec May 20 2025
Filed May 22 2025 · 5:30 PM ET EXELSALE Exelixis, Inc. $6.5M
136,383 sh across 3 lots
Exec May 14 2025
Filed May 16 2025 · 5:30 PM ET EXELSALE Exelixis, Inc. $388K
10,000 sh × $38.80
Exec Mar 3 2025
Filed Mar 5 2025 · 5:30 PM ET EXELSALE Exelixis, Inc. $353K
10,000 sh × $35.27
Exec Nov 22 2024
Filed Nov 26 2024 · 5:30 PM ET EXELSALE Exelixis, Inc. $1.4M
41,588 sh across 2 lots
Exec Nov 18 2024
Filed Nov 19 2024 · 5:30 PM ET